These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25384441)

  • 41. Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals.
    Bonin CRB; Fernandes GC; de Menezes Martins R; Camacho LAB; Teixeira-Carvalho A; da Mota LMH; de Lima SMB; Campi-Azevedo AC; Martins-Filho OA; Dos Santos RW; Lobosco M;
    BMC Bioinformatics; 2020 Dec; 21(Suppl 17):551. PubMed ID: 33308151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tolerance and humoral immune response to the yellow fever vaccine in sickle cell disease children treated with hydroxyurea: a multicentre prospective study.
    Koehl B; Aupiais C; Schinckel N; Mornand P; Odièvre MH; Niakate A; Brousse V; Ithier G; Missud F; Holvoet L; Benkerrou M; Sorge F; Faye A
    J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33550421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The elderly, the young and the pregnant traveler -- A retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever vaccination.
    Jaeger VK; Tschudi N; Rüegg R; Hatz C; Bühler S
    Travel Med Infect Dis; 2015; 13(6):475-84. PubMed ID: 26526774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suspected YF-AND after yellow fever vaccination in Finland.
    Jääskeläinen AJ; Huhtamo E; Kivioja R; Domingo C; Vene S; Kallio-Kokko H; Niedrig M; Tienari PJ; Vapalahti O
    J Clin Virol; 2014 Nov; 61(3):444-7. PubMed ID: 25223921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Yellow fever vaccination - Once in a lifetime?
    Grobusch MP; van Aalst M; Goorhuis A
    Travel Med Infect Dis; 2017; 15():1-2. PubMed ID: 28013052
    [No Abstract]   [Full Text] [Related]  

  • 46. Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children.
    Idoko OT; Mohammed N; Ansah P; Hodgson A; Tapia MD; Sow SO; Chowdhury PR; Niedrig M; Saathoff E; Kampmann B
    Expert Rev Vaccines; 2019 Aug; 18(8):867-875. PubMed ID: 31269829
    [No Abstract]   [Full Text] [Related]  

  • 47. Vaccinations for international travellers travelling from Greece.
    Pavli A; Spilioti A; Lymperi I; Katerelos P; Maltezou HC
    Travel Med Infect Dis; 2013; 11(4):225-30. PubMed ID: 23433917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis.
    Farez MF; Correale J
    Arch Neurol; 2011 Oct; 68(10):1267-71. PubMed ID: 21670384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.
    Cetron MS; Marfin AA; Julian KG; Gubler DJ; Sharp DJ; Barwick RS; Weld LH; Chen R; Clover RD; Deseda-Tous J; Marchessault V; Offit PA; Monath TP
    MMWR Recomm Rep; 2002 Nov; 51(RR-17):1-11; quiz CE1-4. PubMed ID: 12437192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Yellow fever in Brazil: Epidemiological aspects and implications for travelers.
    Chaves TDSS; Orduna T; Lepetic A; Macchi A; Verbanaz S; Risquez A; Perret C; Echazarreta S; Rodríguez-Morales AJ; Lloveras SC
    Travel Med Infect Dis; 2018; 23():1-3. PubMed ID: 29751132
    [No Abstract]   [Full Text] [Related]  

  • 51. Shortage of yellow fever vaccination: A travel medicine emergency for Chilean travellers.
    Weitzel T; Vial P; Perret C; Aguilera X
    Travel Med Infect Dis; 2019; 28():1-2. PubMed ID: 30708130
    [No Abstract]   [Full Text] [Related]  

  • 52. Acceptance of yellow fever vaccine in the older traveller: a cohort study.
    Ferrara P; Masuet-Aumatell C; Ramon-Torrell JM
    Acta Biomed; 2021 Sep; 92(4):e2021098. PubMed ID: 34487067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Yellow fever vaccination: update on rare and severe adverse effects].
    Receveur MC; Bruyand M; Pistone T; Malvy D
    Med Mal Infect; 2009 Apr; 39(4):234-41. PubMed ID: 19167852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of travel health advice in a French travel medicine and vaccine center: a prospective observational study.
    Bouldouyre MA; De Verdière NC; Pavie J; De Castro N; Ponscarme D; Hamane S; Rachline A; Ferret S; Molina JM
    J Travel Med; 2012; 19(2):76-83. PubMed ID: 22414031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination.
    Wieten RW; Jonker EF; van Leeuwen EM; Remmerswaal EB; Ten Berge IJ; de Visser AW; van Genderen PJ; Goorhuis A; Visser LG; Grobusch MP; de Bree GJ
    PLoS One; 2016; 11(3):e0149871. PubMed ID: 26977808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
    Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
    Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety of the yellow Fever vaccine: a retrospective study.
    Nordin JD; Parker ED; Vazquez-Benitez G; Kharbanda EO; Naleway A; Marcy SM; Molitor B; Kuckler L; Baggs J
    J Travel Med; 2013; 20(6):368-73. PubMed ID: 24118538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inadequate protection against yellow fever of children visiting endemic areas.
    Potasman I; Pick N; Stringer C; Zuckerman JN
    Am J Trop Med Hyg; 2001 Dec; 65(6):954-7. PubMed ID: 11792005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Yellow fever vaccination: how much is enough?
    Massad E; Coutinho FA; Burattini MN; Lopez LF; Struchiner CJ
    Vaccine; 2005 Jun; 23(30):3908-14. PubMed ID: 15917112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clustered lot quality assurance sampling: a tool to monitor immunization coverage rapidly during a national yellow fever and polio vaccination campaign in Cameroon, May 2009.
    Pezzoli L; Tchio R; Dzossa AD; Ndjomo S; Takeu A; Anya B; Ticha J; Ronveaux O; Lewis RF
    Epidemiol Infect; 2012 Jan; 140(1):14-26. PubMed ID: 21418714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.